Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Cannabis Sciences Reports on introduction of H.Res. 6187

Published: Tuesday, August 07, 2012
Last Updated: Tuesday, August 07, 2012
Bookmark and Share
Initiative by reps. Himes and Lee requests $100 million to establish AIDS cure research program.

The executive staff of Cannabis Science are analyzing the near term implications of House Resolution 6187, introduced by Rep. James Himes (D-CT) and Rep. Barbara Lee (D-CA) on July 25, 2012 and referred to the Committee on Armed Services, and the Committee on Energy and Commerce. HR 6187 calls for a $100 million, 5-year appropriation to establish an AIDS cure research program under the Congressionally Directed Medical Research Program of the Department of Defense to support the discovery of a cure and new therapies for HIV/AIDS.

H.Res. 6187, The Cure for AIDS Act , introduced and referred to committee this July 25th, would fund research on new antiretrovirals, vaccine development, investigations into novel approaches to controlling viral diversity in highly restricted sanctuary regions and other means of addressing disease progression.

Dr. Robert Melamede, President and CEO of Cannabis Science stated, "Cannabis Science is very excited by the opportunity of this new program proposed by House Resolution 6187 to take further advantage of the momentum generated by AIDS 2012 and the consistent leadership of Representatives Lee and Himes in addressing the global AIDS crisis. This legislation serves to bring further attention to the immediate need of federal facilitation of new drug development to address the persistence of the AIDS pandemic on a global scale. New legislative initiatives such as the Cure for AIDS Act well help to move forward promising new therapeutics for HIV, such as our new CS-TATI-1 program, and potential cures. This bill encompasses support for both basic science and translational research in the pursuit of progress in treating HIV."

The U.S. government has historically facilitated HIV drug development through RO1 and SB1 grants and inclusion in the AIDS Clinical Trials Groups (ACTG), HIV Prevention Trails Network (HPTN), HIV Vaccine Trials Network (HVTN) or Military HIV Research Program (MHRP) federally funded research networks, which has led towards the development of 5 classes of antiretroviral therapy representing 20 HIV drugs.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos